Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 1999 Jun;67(6):2884-90.
doi: 10.1128/IAI.67.6.2884-2890.1999.

Antibody responses in the lower respiratory tract and male urogenital tract in humans after nasal and oral vaccination with cholera toxin B subunit

Affiliations
Comparative Study

Antibody responses in the lower respiratory tract and male urogenital tract in humans after nasal and oral vaccination with cholera toxin B subunit

A Rudin et al. Infect Immun. 1999 Jun.

Abstract

Nasal vaccine delivery is superior to oral delivery in inducing specific immunoglobulin A (IgA) and IgG antibody responses in the upper respiratory tract. Although an antibody response in the nasal passages is important in protecting against primary colonization with lung pathogens, antibodies in the lungs are usually required as well. We immunized 15 male volunteers twice nasally or orally with cholera toxin B subunit (CTB) and determined the specific antibody levels in serum, bronchoalveolar lavage (BAL) fluid, and urine before and 2 weeks after immunization. Nasal immunization induced fivefold increases in the levels of specific IgA antibodies in BAL fluid of most volunteers, whereas there were no significant specific IgA responses after oral immunization. The specific IgG antibody level increased eightfold in BAL fluid in the nasally vaccinated subjects, and the major part of IgG had most probably been transferred from serum. Since the specific IgG response in serum was lower in the individuals vaccinated orally, the IgG response in BAL fluid in this group was also lower and not significant. In conclusion, nasal immunization is also preferable to the oral route when vaccinating against lower respiratory tract infections, and a systemic immune response is considerably more important in the lower than in the upper respiratory tract. Moreover, both nasal and oral immunizations were able to stimulate 6- to 10-fold specific IgA and IgG responses in urine in about half of the individuals, which indicates that distant mucosal vaccination might be used to prevent adhesion of pathogens to the urogenital tract.

PubMed Disclaimer

Figures

FIG. 1
FIG. 1
CTB-specific increases in IgA and IgG levels in serum, BAL fluid, and urine after two nasal or two oral vaccinations. The individual titers, or titers adjusted to the total Ig content, from the time points before and 2 weeks after vaccination are shown.

References

    1. Abitorabi M A, Mackay C R, Jerome E H, Osorio O, Butcher E C, Erle D J. Differential expression of homing molecules on recirculating lymphocytes from sheep gut, peripheral, and lung lymph. J Immunol. 1996;156:3111–3117. - PubMed
    1. Banks D E, Morgan J E, Deshazo R D, Weissman D, Rodriguez F H, Barkman H W, Salvaggio J E. Reliability of cell counts and protein determinations in serial bronchoalveolar lavage procedures performed on healthy volunteers. Am J Med Sci. 1990;300:275–282. - PubMed
    1. Belshe R B, Mendelman P M, Treanor J, King J, Gruber W C, Piedra P, Bernstein D I, Hayden F G, Kotloff K, Zangwill K, Iacuzio D, Wolff M. The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenzavirus vaccine in children. N Engl J Med. 1998;338:1405–1412. - PubMed
    1. Bergquist C, Johansson E-L, Lagergård T, Holmgren J, Rudin A. Intranasal vaccinatino of humans with recombinant cholera toxin B subunit induces systemic and local antibody responses in the upper respiratory tract and the vagina. Infect Immun. 1997;65:2676–2684. - PMC - PubMed
    1. Bergquist C, Lagergård T, Lindblad M, Holmgren J. Local and systemic responses to dextran-cholera toxin B subunit conjugates. Infect Immun. 1995;63:2021–2025. - PMC - PubMed

Publication types

LinkOut - more resources